Wuxi Pharmatech Inc., of Shanghai, appointed Hua Mu senior vice president of operations and global head of the product development service and partnership business unit. Read More
Nuvilex Inc., of Silver Spring, Md., said partner Austrianova Singapore Pty Ltd., of Singapore, signed a contract to establish regional headquarters and an R&D facility at the Thailand Science Park near Bangkok. The facilities will be used for the encapsulation, using the Cell-in-the-Box technology, of live cancer prodrug-activating cells that are part of Nuvilex’s pancreatic cancer treatment and that will be used in the company’s late-phase trials. Read More
SHANGHAI – After a year of revisions, China’s Ministry of Commerce (MOFCOM) revealed its anticipated new “simple rules” for mergers and acquisitions. The move signals the government’s intentions toward fast-tracking deals that don’t trigger competition issues, but with the caveat that certain conditions apply. Read More
Fearing that India’s lax attitudes toward drug patents might spread to other developing countries, U.S. drugmakers want the U.S. Trade Representative (USTR) to make an example of the country by once again branding it the worst of the worst in not honoring intellectual property (IP) rights. Read More
SHANGHAI – Bayer AG’s recent purchase of traditional Chinese medicine (TCM) maker Dihon Pharmaceutical Group Co. was viewed by some as a step closer to the legitimization of the TCM drug market, one that occupies about a third to a half of all revenues here. Read More
HONG KONG – A listed Chinese medical diagnostic service provider and a South Korean investment company have launched a new fund to target biopharmaceutical and health care companies. Read More
SINGAPORE – Aware that Asian markets are growing fast and will account for half of global GDP in a few decades, national and multinational biopharmaceutical firms are looking to expand their presence in the region while stepping up their innovative capabilities. Read More
